三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

交易中 04-01 10:20:33

23.880

+1.240

+5.48%

最高24.040	最低22.720	成交量1,473万
今开23.400	昨收22.640	日振幅5.83%
总市值606.07亿	流通市值606.07亿	总股本25.38亿
成交额3.45亿	换手率0.58%	流通股本25.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":23.88,"timestamp":1775010032073,"preClose":22.64,"halted":0,"volume":14729675,"delay":0,"changeRate":0.054770318021201345,"floatShares":2538000000,"shares":2538000000,"eps":3.90540667455844,"marketStatus":"交易中","change":1.24,"latestTime":"04-01 10:20:33","open":23.4,"high":24.04,"low":22.72,"amount":344817128,"amplitude":0.058304,"askPrice":23.9,"askSize":39000,"bidPrice":23.88,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":3.90540667455844,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1775016000000},"marketStatusCode":2,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":22.64,"dividendRate":0.010469,"openAndCloseTimeList":[[1775007000000,1775016000000],[1775019600000,1775030400000]],"volumeRatio":2.49708,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"1127457182","title":"三生制药发布2025年业绩：创新研发与全球合作双轮驱动 营收突破百亿大关","url":"https://stock-news.laohu8.com/highlight/detail?id=1127457182","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127457182?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:13","pubTimestamp":1774959194,"startTime":"0","endTime":"0","summary":"三生制药公布2025年度业绩报告，公司凭借创新研发与全球合作两大核心引擎的强劲驱动，年度营收首次突破百亿元人民币大关。这一里程碑式的增长凸显了公司战略布局的有效性，以及在生物医药领域的持续领先优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK1161","BK1593","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623630663","title":"港股三生制药盘中一度跌近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623630663","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623630663?lang=zh_cn&edition=full","pubTime":"2026-03-31 15:06","pubTimestamp":1774940802,"startTime":"0","endTime":"0","summary":"每经AI快讯，3月31日，三生制药(01530.HK)盘中一度跌近8%，截至发稿跌6.75%，报22.64港元，成交额12.08亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603313690333488.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690333488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000165453.HKD","BK1161","BK1593","VXUS","BK4585","BK4588","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623373124","title":"【券商聚焦】中信证券：基本医保基金收支和结余整体保持稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2623373124","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623373124?lang=zh_cn&edition=full","pubTime":"2026-03-31 08:59","pubTimestamp":1774918794,"startTime":"0","endTime":"0","summary":"2026年2月医保支出同比增速回升，收支剪刀差有所收窄。该机构预计在医保基金监管力度持续加大，DRG/DIP精细化管理的推动下，2026年全年基金结余率或将延续此前节奏略有提升。医疗健康产业政策改革进入密集期，建议持续关注政策驱动下的医疗健康产业投资机会。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977773","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","09688","LU1328615791.USD","BK0276","09926","LU0405327148.USD","LU1719994722.HKD","06160","06821","LU0307460666.USD","LU0634319403.HKD","03933","BK1147","02196","LU2488822045.USD","01099","HK0000165453.HKD","BK1191","IE00B543WZ88.USD","LU1969619763.USD","LU2495084118.USD","LU0348766576.USD","06030","LU1997245177.USD","LU0348783233.USD","BK1583","IE00BPRC5H50.USD","BK1588","02268","600030","01789","BK1161","BK1100","LU1115378108.SGD","BK1617","01530","LU0348735423.USD","LU2399975544.HKD","BK0012","BK1515","02367","LU1255011170.USD","LU1770034418.SGD","02228","LU0405327494.USD","LU1303224171.USD","LU2148510915.USD","BK1593","LU2476274308.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623496733","title":"三生制药(01530)发布年度业绩 股东应占纯利增加305.8%至84.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623496733","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623496733?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:29","pubTimestamp":1774880949,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药 发布截至2025年12月31日止年度全年业绩，集团收入增加94.3%至人民币176.96亿元。毛利增加108.8%至人民币163.47亿元，毛利率为92.4%。母公司拥有人应占纯利增加305.8%至人民币84.82亿元。末期股息每股25港仙。根据IQVIA，于2025年，按销售额计，特比澳在中国内地血小板减少症治疗市场的份额为60.4%。凭借两种rhEPO产品，二十多年来，本集团一直为中国内地rhEPO市场龙头，于2025年共占39.6%的总市场份额。蔓迪在中国内地防脱发药物市场亦占主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"三生制药(01530)发布年度业绩 股东应占纯利增加305.8%至84.82亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","BK1583","BK1161","BK1593","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1134927417","title":"三生制药拟分拆蔓迪国际赴港主板上市 并以实物分派方式派发附条件特别股息","url":"https://stock-news.laohu8.com/highlight/detail?id=1134927417","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134927417?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:41","pubTimestamp":1774878064,"startTime":"0","endTime":"0","summary":"三生制药3月30日公布，董事会已决定推进旗下附属公司蔓迪国际于香港联交所主板独立上市的建议分拆，并宣布拟由股份溢价账户派发附条件特别股息，方式为向合资格股东实物分派公司持有的全部蔓迪股份。该分派将在建议分拆完成前即时实施，股东将按其于记录日期的持股比例获配蔓迪股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183379223","title":"异动解读 | 创新药板块资金面充裕，三生制药盘中大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=1183379223","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183379223?lang=zh_cn&edition=full","pubTime":"2026-03-27 10:18","pubTimestamp":1774577884,"startTime":"0","endTime":"0","summary":"三生制药(01530)今日盘中大涨5.71%，引起了市场的广泛关注。消息面上，三生制药所在的创新药概念板块今日集体走高。根据机构分析，当前医药板块资金面充裕，绝大多数企业仍保持了1年以上的研发资金覆盖能力，能够有效支撑后续临床试验推进、管线拓展及技术创新，为行业长期高质量发展奠定了稳健的财务基础。这一积极的财务基本面分析，增强了市场对包括三生制药在内的创新药企业长期发展潜力的信心，从而推动了股价的上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9b241a979bfd22b774f426314475f336","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","LU2476274720.SGD","LU0348767384.USD","IE00B543WZ88.USD","LU0417516738.SGD","LU0417516571.SGD","LU2399975544.HKD","LU0348766576.USD","BK1585","BK1500","BK1161","BK1141","LU1303224171.USD","02196","02268","06821","LU0307460666.USD","06160","LU1770034418.SGD","IE00BPRC5H50.USD","02367","LU0540923850.HKD","BK1207","LU2488822045.USD","LU2328871848.SGD","09688","01099","LU0417516902.SGD","LU1115378108.SGD","BK1197","LU0348784397.USD","01530","02228","LU2778985437.USD","BK1583","BK1617","LU1794554557.SGD","BK1588","01789","LU0348735423.USD","BK1574","03933","BK1191","LU0348827113.USD","LU2476274308.USD","CXO","BK1593","09926","03329","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620286154","title":"三生制药(01530.HK)拟3月30日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620286154","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620286154?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:37","pubTimestamp":1773740224,"startTime":"0","endTime":"0","summary":"格隆汇3月17日丨三生制药(01530.HK)宣布，公司将于2026年3月30日(星期一)举行董事会会议，藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度之年度业绩及其发布，并考虑派发截至2025年12月31日止年度之末期股息(如有)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260317/32075140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1593","BK1161","BK1583","01530","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620449806","title":"招银国际：料中国医疗行业基本面加速向好 推荐买信达生物(01801)三生制药(01530)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2620449806","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620449806?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:07","pubTimestamp":1773731228,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，MSCI中国医疗指数2026年初至今累计上涨0.6%，跑赢MSCI中国指数3.5%。医药行业近期明显回调，特别是创新药板块回调幅度较大。同时，AI制药技术突破与中国创新药踏出海外BD的爆发形成双重共振，该行预计行业基本面加速向好。该行表示，推荐买入信达生物、三生制药、加科思、固生堂 、药明合联，目标价分别110.62港元、37.43港元、10.34港元、44.95港元及88港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d0f3c5bccb622a532fbc5668691928ff","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02273","BK1161","BK1219","LU2097828474.EUR","LU2242644610.SGD","01801","LU2328871848.SGD","BK1141","BK1593","LU2097828557.USD","01167","BK1583","LU2097828714.EUR","01530","BK1589","02268","LU2097828631.EUR","LU0455707207.USD","SG9999014674.SGD","HK0000165453.HKD","LU0502904849.HKD","BK1574","LU1969619763.USD","159891","LU2097828805.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620641495","title":"港股创新药概念震荡走高 三生制药涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620641495","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620641495?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:51","pubTimestamp":1773715883,"startTime":"0","endTime":"0","summary":"港股创新药概念震荡走高 三生制药涨超7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674281470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","VXUS","HK0000165453.HKD","06978","BK1161","BK1583","BK4588","BK4585","159992","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618781922","title":"每日卖空追踪 | 三生制药 03月11日卖空量成交118.75万股，卖空比例为6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618781922","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618781922?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217822,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月11日，涨0.18%，卖空量成交118.75万股，较上一交易日减少45.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163248a460b5a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163248a460b5a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618649157","title":"每日卖空追踪 | 三生制药 03月09日卖空量成交96.8万股，卖空比例为2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618649157","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618649157?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045022,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月09日，跌5.37%，卖空量成交96.8万股，较上一交易日减少52.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163245a45ae680&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163245a45ae680&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","HK0000165453.HKD","BK1161","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617819146","title":"每日卖空追踪 | 三生制药 03月06日卖空量成交158.35万股，卖空比例为3.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617819146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617819146?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785822,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月06日，涨9.42%，卖空量成交158.35万股，较上一交易日减少2.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163241a4535a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","HK0000165453.HKD","01530","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617066845","title":"创新药板块强势 三生制药(01530)涨9.83% 机构指业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617066845","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617066845?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:41","pubTimestamp":1772764875,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块强势，三生制药 涨9.83%，基石药业-B涨6.84%，荣昌生物涨6.31%，映恩生物-B涨5.98%，四环医药涨5.76%，恒瑞医药涨5.77%，君圣泰医药-B涨5.58%，康诺亚-B涨5.31%，复宏汉霖涨5.02%。交银国际表示，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MGQ5MWNhYjgxMjA0ZDU3OGI4Y2EzYTk1OWIyNGM1NTg2NTUyNjEzMTk5Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976042","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","HK0000306701.USD","LU1023057109.AUD","HK0000320264.USD","LU2328871848.SGD","LU0359201885.HKD","01530","HK0000165453.HKD","02511","09995","HK0000500386.USD","HK0000320223.HKD","HK0000252152.HKD","HK0000252160.HKD","LU1969619763.USD","02616","LU2543165471.USD","BK1600","02696","BK1583","HK0000306685.HKD","BK1515","02162","09606","01276","BK1587","00460","BK1191","06978","LU0359201612.USD","159992","LU0359202008.SGD","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617184681","title":"三生制药盘中异动 早盘急速拉升5.07%报20.740港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617184681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617184681?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:43","pubTimestamp":1772761432,"startTime":"0","endTime":"0","summary":"2026年03月06日早盘09时43分，三生制药股票出现波动，股价快速拉升5.07%。截至发稿，该股报20.740港元/股，成交量659.81万股，换手率0.26%，振幅6.69%。资金方面，该股资金流入7450.45万港元，流出2932.11万港元。三生制药股票所在的药品行业中，整体涨幅为0.18%。其相关个股中，和黄医药、劲方医药-B、三生制药涨幅较大，振幅较大的相关个股有和黄医药、三生制药、英硅智能，振幅分别为7.03%、6.48%、6.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306094352a6a8d0b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306094352a6a8d0b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1583","01530","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617919503?lang=zh_cn&edition=full","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","SG9999014674.SGD","BK1593","09939","IE00BPRC5H50.USD","LU0348766576.USD","LU0348825331.USD","02367","02228","03933","IE00B5MMRT66.SGD","LU1794554557.SGD","LU1770034418.SGD","LU0588546209.SGD","09688","HK0000165453.HKD","LU2399975544.HKD","BK1574","LU1719994722.HKD","01789","BK1197","LU0348735423.USD","LU0348784397.USD","LU2476274308.USD","01530","LU0640798160.USD","LU1303224171.USD","02196","LU0417516571.SGD","LU0540923850.HKD","LU1961090484.USD","LU2488822045.USD","SG9999004311.SGD","LU0348827113.USD","LU1115378108.SGD","LU2328871848.SGD","LU2778985437.USD","01099","BK1207","LU0348783233.USD","BK1141","BK1191","LU0561508036.HKD","03329","06160","159938","02268","09926","LU2476274720.SGD","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616104537","title":"每日卖空追踪 | 三生制药 03月04日卖空量成交54.8万股，卖空比例为2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616104537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616104537?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613022,"startTime":"0","endTime":"0","summary":"三生制药北京时间03月04日，跌3.53%，卖空量成交54.8万股，较上一交易日减少69.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163250a44a6bfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163250a44a6bfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","01530","BK1161","BK1583","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616191537","title":"三生制药盘中异动 临近午盘股价大跌5.00%报19.360港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616191537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616191537?lang=zh_cn&edition=full","pubTime":"2026-03-04 11:34","pubTimestamp":1772595288,"startTime":"0","endTime":"0","summary":"2026年03月04日临近午盘11时34分，三生制药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报19.360港元/股，成交量1062.66万股，换手率0.42%，振幅5.50%。资金方面，该股资金流入7906.12万港元，流出1.02693亿港元。最近的财报数据显示，该股实现营业收入47.76亿港元，净利润14.89亿港元，每股收益0.63港元，毛利40.75亿港元，市盈率21.77倍。三生制药股票所在的药品行业中，整体跌幅为0.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113448a44958e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304113448a44958e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000165453.HKD","BK1583","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153034423","title":"三生制药（01530）2月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1153034423","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153034423?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:36","pubTimestamp":1772527001,"startTime":"0","endTime":"0","summary":"三生制药（01530）于2026年3月3日发布2026年2月股份变动月报表。公告显示，截至2026年2月28日，公司注册股本维持不变，数量为50,000,000,000股，面值每股0.00001美元，注册股本总额仍为50万美元。期末已发行股份总数为2,538,005,412股，与月初持平，期间无新增发行、回购或注销行为，亦无库存股变化。\n根据公告，公司已确认符合适用的公众持股量要求。期内无股份期权、权证或可换股票据等事项变动。公告由公司秘书黎少娟签署，确认遵守香港联交所《上市规则》及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538865?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","01789","LU0348827113.USD","06978","LU1720050803.USD","SG9999014674.SGD","LU1303224171.USD","LU0588546209.SGD","LU2488822045.USD","LU0307460666.USD","BK1100","BK1585","LU0348784397.USD","LU1961090484.USD","LU1794554557.SGD","LU1115378108.SGD","IE00B543WZ88.USD","LU0348783233.USD","LU2399975544.HKD","BK1617","LU2328871848.SGD","BK1161","03933","SG9999004311.SGD","01099","02196","HK0000165453.HKD","LU1969619763.USD","BK1583","159992","BK1574","BK1141","IE00BPRC5H50.USD","LU2476274720.SGD","06160","LU1251922891.USD","BK1515","LU0634319403.HKD","02228","LU0348735423.USD","LU0640798160.USD","02367","02268","09688","09926","BK1197","IE00B5MMRT66.SGD","BK1207","LU0561508036.HKD","01530"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0319},{"period":"3month","weight":-0.0637},{"period":"6month","weight":-0.2664},{"period":"1year","weight":0.9081},{"period":"ytd","weight":-0.0637}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0692},{"period":"3month","weight":-0.0329},{"period":"6month","weight":-0.0916},{"period":"1year","weight":0.0722},{"period":"ytd","weight":-0.0329}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.00666},{"month":2,"riseRate":0.454545,"avgChangeRate":0.00178},{"month":3,"riseRate":0.818182,"avgChangeRate":0.113214},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045323}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}